Equity
€152,388 ▲ 22.5%
DOCTEUR D'ATRIA Michaël paid out €150,000 in dividends. That is 84% of the 2025 profit.
DOCTEUR D'ATRIA Michaël
Lifetime
3 annual accounts with figures on one time axisGross marginpeak €234,510 (2025)
€234,510▲ 63.5%
Resultpeak €177,972 (2025)
€177,972▲ 64.4%
Equitypeak €152,388 (2025)
€152,388▲ 22.5%
Debts
€131,874▲ 266%
Board1 name since 2023
1 directorD'ATRIA Michaël
Documentsfilings and deeds
20-07-202611 days before the deadline
2025micro format
Gross margin from €143,460 to €234,510Result from €108,233 to €177,972Dividend €150,000Equity from €124,416 to €152,388Debts from €36,022 to €131,874Cash from €70,106 to €172,418
Key points
from the 2025 annual accountsResult
€177,972 ▲ 64.4%
The result rose in 2025 from €108,233 to €177,972.
Turnover
≈ €440,000 estimated
The micro format states no turnover.
Debts
€131,874 ▲ 266%
Debts rose by €95,852 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Liquidity
2.15 was 4.42 in 2024
Short-term debts rose from €36,022 to €131,874.
Position in the sector
€177,972
Higher net result than 85% of companies in human health. Sector median €60,072 · 20,736 companies.
Checked score
95
Excellent
Financially stronger than 62% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,179 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025lowest value
09-2025: < 0.1%● unchanged vs 08-2025lowest value
10-2025: < 0.1%● unchanged vs 09-2025lowest value
11-2025: < 0.1%● unchanged vs 10-2025lowest value
12-2025: < 0.1%● unchanged vs 11-2025lowest value
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: 0.1%▲ +0.1 percentage points vs 06-2026highest value
08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
1 change of registered office in 24 months
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 2.15, cash €172,418
Figures for financial year 2025 (filed on 20-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 43% of them on solvency, 59% on liquidity, 80% on profitability and 66% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as DOCTEUR D'ATRIA Michaël has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of DOCTEUR D'ATRIA Michaël itself is lower: < 0.1% within 12 months. It rests on far more data about DOCTEUR D'ATRIA Michaël than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for DOCTEUR D'ATRIA Michaël. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €14,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.15 (4.42 in 2024), above the usual 1.5. Short-term debt is 46.4% and cash 60.7% of total assets. 46.4% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
11 days early
2024
16 days early
2023
20 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 3 accounts on average 16 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 15 July (3 of the last 3 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered office moved from Liège to Beaufays
New registered office: rue du Clos Colas 6, 4052 Beaufays · Previous registered office: Quai de Rome 22 boîte 92, 4000 Liège · General meeting of 01-01-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0802473575
Incorporation
Founding capital of €2,500, 100 shares · Founder: D'ATRIA Michaël · Appointment: D'ATRIA Michaël (director) · published on 09-06-2023 · Gazette deed
First establishment
Quai de Rome 22, Liège
Comparable companies
same main activity, similar in size and age| Company | Total assets | Gross margin | Solvency | Staff |
|---|---|---|---|---|
| DOCTEUR D'ATRIA Michaël Chaudfontaine | €284,262 | €234,510 | 53.6% | - |
| Centre médical A.R. Liège | €327,638 | €234,338 | 93.5% | - |
| VANH OPHTALMO Dalhem | €329,104 | €224,824 | 85.5% | - |
| Van Moorsel Endocrinologie Maaseik | €288,095 | €230,703 | 86.8% | - |
| Dr. Tache Edegem | €305,086 | €237,232 | 77.1% | 0.4 |
| Dr. Sara De Burghgraeve Bruges | €273,243 | €213,454 | 79.8% | - |
| AW ANESTHESIE Wavre | €293,886 | €244,118 | 3.4% | - |
These companies have the same main activity as DOCTEUR D'ATRIA Michaël: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €273,000 and €329,000, founded between 2022 and 2023.
Official details
Source: KBO- Status
- Active since 07-06-2023Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.346.622.0204000 Liège, since 07-06-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 08-12-2025
Annual accounts 2025
- Total assets
- €284,262▲ 77.2%
- Filing
- Filed on 20-07-2026, 11 days before the end of the filing period
Insights on DOCTEUR D'ATRIA Michaël
DOCTEUR D'ATRIA Michaël files the micro format. That format states no turnover. The gross margin rose from €18,122 in 2023 to €234,510 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DOCTEUR D'ATRIA Michaël
- What is the company number of DOCTEUR D'ATRIA Michaël?
- The company number of DOCTEUR D'ATRIA Michaël is 0802.473.575. The VAT number is the same number with BE in front: BE 0802.473.575.
- Where is DOCTEUR D'ATRIA Michaël based?
- The registered office is at Rue du Clos Colas 6, 4052 Chaudfontaine.Company details
- What does DOCTEUR D'ATRIA Michaël do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DOCTEUR D'ATRIA Michaël?
- DOCTEUR D'ATRIA Michaël is a private limited company (BV).
- When was DOCTEUR D'ATRIA Michaël founded?
- DOCTEUR D'ATRIA Michaël was founded on 07-06-2023.
- Is DOCTEUR D'ATRIA Michaël still active?
- Yes, DOCTEUR D'ATRIA Michaël is an active enterprise in the KBO register.
- What is the turnover of DOCTEUR D'ATRIA Michaël?
- The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €234,510 and 42 comparable companies (NACE 86220). It probably lies between €370,000 and €570,000.Financials
- Is DOCTEUR D'ATRIA Michaël profitable?
- In financial year 2025, DOCTEUR D'ATRIA Michaël made a profit of €177,972.
- Where can I find the annual accounts of DOCTEUR D'ATRIA Michaël?
- DOCTEUR D'ATRIA Michaël filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DOCTEUR D'ATRIA Michaël due?
- DOCTEUR D'ATRIA Michaël must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.